Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Pacira Biosciences Inc (PCRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q4 | 103,081 | 0.01 | Reduce 50.35% | 0.01 | $33.74 | $3,477,953 | SEC |
| 2023 Q3 | 207,632 | 0.02 | Reduce 15.00% | <0.01 | $30.68 | $6,370,150 | SEC |
| 2023 Q2 | 244,272 | 0.03 | Add 38.46% | <0.01 | $40.07 | $9,787,979 | SEC |
| 2023 Q1 | 176,425 | 0.02 | Add 112.53% | 0.01 | $40.81 | $7,199,905 | SEC |
| 2022 Q4 | 83,013 | 0.01 | Add 5.71% | <0.01 | $38.61 | $3,205,132 | SEC |
| 2022 Q3 | 78,531 | 0.01 | Add 12.47% | <0.01 | $53.19 | $4,177,000 | SEC |
| 2022 Q2 | 69,825 | 0.01 | Add 46.32% | <0.01 | $58.30 | $4,071,000 | SEC |
| 2022 Q1 | 47,721 | 0.01 | Add 92.18% | <0.01 | $76.32 | $3,642,000 | SEC |
| 2021 Q4 | 24,832 | <0.01 | Buy | <0.01 | $60.16 | $1,494,000 | SEC |